Literature DB >> 8589219

Testing for the presence of immune or cured individuals in censored survival data.

R A Maller1, S Zhou.   

Abstract

In a sample of censored survival times, the presence of an immune proportion of individuals who are not subject to death, failure, or relapse, etc., may be indicated by a relatively high number of individuals with large censored survival times. We summarise some recent theoretical work which justifies analogues of the usual model fitting and testing techniques for such data. In particular, we discuss a 'boundary' test for the presence of immunes in the population and goodness of fit tests for parametric descriptions of the data. The methods are illustrated on some data on the relapse times of leukemia patients.

Entities:  

Mesh:

Year:  1995        PMID: 8589219

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models.

Authors:  A D Tsodikov; J G Ibrahim; A Y Yakovlev
Journal:  J Am Stat Assoc       Date:  2003-12-01       Impact factor: 5.033

2.  Mixture cure model with an application to interval mapping of quantitative trait loci.

Authors:  Mengling Liu; Wenbin Lu; Yongzhao Shao
Journal:  Lifetime Data Anal       Date:  2006-10-25       Impact factor: 1.588

3.  A Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.

Authors:  Megan Othus; Yi Li; Ram C Tiwari
Journal:  J Am Stat Assoc       Date:  2009-09-01       Impact factor: 5.033

4.  Estimating the turning point of the log-logistic hazard function in the presence of long-term survivors with an application for uterine cervical cancer data.

Authors:  Patrick Borges
Journal:  J Appl Stat       Date:  2020-02-03       Impact factor: 1.416

5.  Analysis of Smoking Cessation Patterns Using a Stochastic Mixed-Effects Model With a Latent Cured State.

Authors:  Sheng Luo; Ciprian M Crainiceanu; Thomas A Louis; Nilanjan Chatterjee
Journal:  J Am Stat Assoc       Date:  2008-09-01       Impact factor: 5.033

6.  Bagging survival tree procedure for variable selection and prediction in the presence of nonsusceptible patients.

Authors:  Cyprien Mbogning; Philippe Broët
Journal:  BMC Bioinformatics       Date:  2016-06-07       Impact factor: 3.169

7.  A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.

Authors:  Sarah Flora Jonas; Cyprien Mbogning; Signe Hässler; Philippe Broët
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

8.  A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort.

Authors:  Julianne Duhazé; Signe Hässler; Delphine Bachelet; Aude Gleizes; Salima Hacein-Bey-Abina; Matthieu Allez; Florian Deisenhammer; Anna Fogdell-Hahn; Xavier Mariette; Marc Pallardy; Philippe Broët
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 9.  On estimating the time to statistical cure.

Authors:  Lasse H Jakobsen; Therese M-L Andersson; Jorne L Biccler; Laurids Ø Poulsen; Marianne T Severinsen; Tarec C El-Galaly; Martin Bøgsted
Journal:  BMC Med Res Methodol       Date:  2020-03-26       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.